1. Home
  2. ZYXI vs TEI Comparison

ZYXI vs TEI Comparison

Compare ZYXI & TEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • TEI
  • Stock Information
  • Founded
  • ZYXI 1996
  • TEI 1993
  • Country
  • ZYXI United States
  • TEI United States
  • Employees
  • ZYXI N/A
  • TEI N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TEI Finance Companies
  • Sector
  • ZYXI Health Care
  • TEI Finance
  • Exchange
  • ZYXI Nasdaq
  • TEI Nasdaq
  • Market Cap
  • ZYXI 72.3M
  • TEI 265.9M
  • IPO Year
  • ZYXI N/A
  • TEI N/A
  • Fundamental
  • Price
  • ZYXI $2.11
  • TEI $6.12
  • Analyst Decision
  • ZYXI Buy
  • TEI
  • Analyst Count
  • ZYXI 3
  • TEI 0
  • Target Price
  • ZYXI $6.00
  • TEI N/A
  • AVG Volume (30 Days)
  • ZYXI 257.9K
  • TEI 142.4K
  • Earning Date
  • ZYXI 07-28-2025
  • TEI 01-01-0001
  • Dividend Yield
  • ZYXI N/A
  • TEI 10.51%
  • EPS Growth
  • ZYXI N/A
  • TEI N/A
  • EPS
  • ZYXI N/A
  • TEI N/A
  • Revenue
  • ZYXI $172,401,000.00
  • TEI N/A
  • Revenue This Year
  • ZYXI N/A
  • TEI N/A
  • Revenue Next Year
  • ZYXI $19.55
  • TEI N/A
  • P/E Ratio
  • ZYXI N/A
  • TEI N/A
  • Revenue Growth
  • ZYXI N/A
  • TEI N/A
  • 52 Week Low
  • ZYXI $1.66
  • TEI $4.35
  • 52 Week High
  • ZYXI $10.62
  • TEI $5.39
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 39.15
  • TEI 66.40
  • Support Level
  • ZYXI $2.31
  • TEI $6.01
  • Resistance Level
  • ZYXI $2.72
  • TEI $6.09
  • Average True Range (ATR)
  • ZYXI 0.18
  • TEI 0.09
  • MACD
  • ZYXI -0.04
  • TEI -0.00
  • Stochastic Oscillator
  • ZYXI 7.79
  • TEI 70.00

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About TEI Templeton Emerging Markets Income Fund Inc.

Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments, and Money Market Funds.

Share on Social Networks: